|
1
|
Klangjorhor J, Pongnikorn D, Sittiju P, Phanphaisarn A, Chaiyawat P, Teeyakasem P, Kongdang P, Moonmuang S, Waisri N, Daoprasert K, et al: Descriptive epidemiology of soft tissue sarcomas and gastrointestinal stromal tumors in Thailand. Sci Rep. 12(12824)2022.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Verschoor AJ, Bovée JVMG and Overbeek LIH: PALGA group. Hogendoorn PCW and Gelderblom H: The incidence, mutational status, risk classification and referral pattern of gastro-intestinal stromal tumours in the Netherlands: A nationwide pathology registry (PALGA) study. Virchows Arch. 472:221–229. 2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Zhu H, Yang G, Ma Y, Huo Q, Wan D and Yang Q: Update of epidemiology, survival and initial treatment in patients with gastrointestinal stromal tumour in the USA: A retrospective study based on SEER database. BMJ Open. 13(e072945)2023.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Mantese G: Gastrointestinal stromal tumor: Epidemiology, diagnosis, and treatment. Curr opin gastroen. 35:555–559. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Xu L, Ma Y, Wang S, Feng J, Liu L, Wang J, Liu G, Xiu D, Fu W, Zhan S, et al: Incidence of gastrointestinal stromal tumor in Chinese urban population: A national population-based study. Cancer Med. 10:737–744. 2021.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Khan J, Ullah A, Waheed A, Karki NR, Adhikari N, Vemavarapu L, Belakhlef S, Bendjemil SM, Mehdizadeh Seraj S, Sidhwa F, et al: Gastrointestinal stromal tumors (GIST): A population-based study using the SEER database, including management and recent advances in targeted therapy. Cancers (Basel). 14(3689)2022.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Mechahougui H, Michael M and Friedlaender A: Precision oncology in gastrointestinal stromal tumors. Curr Oncol. 30:4648–4662. 2023.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Abdalla TSA, Pieper L, Kist M, Thomaschewski M, Klinkhammer-Schalke M, Zeissig SR, Tol KK, Wellner UF, Keck T and Hummel R: Gastrointestinal stromal tumors of the upper GI tract: Population-based analysis of epidemiology, treatment and outcome based on data from the German clinical cancer registry group. J Cancer Res Clin. 149:7461–7469. 2023.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Alvarez CS, Piazuelo MB, Fleitas-Kanonnikoff T, Ruhl J, Pérez-Fidalgo JA and Camargo MC: Incidence and survival outcomes of gastrointestinal stromal tumors. JAMA Netw Open. 7(e2428828)2024.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Deprez PH, Moons LMG, O toole D, Gincul R, Seicean A, Pimentel-Nunes P, Fernández-Esparrach G, Polkowski M, Vieth M, Borbath I, et al: Endoscopic management of subepithelial lesions including neuroendocrine neoplasms: European society of gastrointestinal endoscopy (ESGE) guideline. Endoscopy. 54:412–429. 2022.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Kim GH: Systematic endoscopic approach for diagnosing gastric subepithelial tumors. Gut Liver. 16:19–27. 2022.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Zackria R and Choi EH: Esophageal schwannoma: A rare benign esophageal tumor. Cureus. 13(e15667)2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
A-Lai GH, Hu JR, Yao P and Lin YD: Surgical treatment for esophageal leiomyoma: 13 years of experience in a high-volume tertiary hospital. Front Oncol. 12(876277)2022.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Park K, Ahn JY, Na HK, Jung KW, Lee JH, Kim DH, Choi KD, Song HJ, Lee GH and Jung HY: Natural history of gastric leiomyoma. Surg Endosc. 38:2726–2733. 2024.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Serrano C, Álvarez R, Carrasco JA, Marquina G, Martínez-García J, Martínez-Marín V, Sala MÁ, Sebio A, Sevilla I and Martín-Broto J: SEOM-GEIS clinical guideline for gastrointestinal stromal tumors (2022). Clin Transl Oncol. 25:2707–2717. 2023.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Serrano C, Martín-Broto J, Asencio-Pascual JM, López-Guerrero JA, Rubió-Casadevall J, Bagué S, García-Del-Muro X, Fernández-Hernández JÁ, Herrero L, López-Pousa A, et al: 2023 GEIS Guidelines for gastrointestinal stromal tumors. Ther Adv Med Oncol. 15(17588359231192388)2023.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Jacobson BC, Bhatt A, Greer KB, Lee LS, Park WG, Sauer BG and Shami VM: ACG clinical guideline: Diagnosis and management of gastrointestinal subepithelial lesions. Am J Gastroenterol. 118:46–58. 2023.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Casali PG, Blay JY, Abecassis N, Bajpai J, Bauer S, Biagini R, Bielack S, Bonvalot S, Boukovinas I, Bovee JVMG, et al: Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS clinical practice guidelines for diagnosis, treatment and follow-up. Ann oncol. 33:20–33. 2022.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Hirota S, Tateishi U, Nakamoto Y, Yamamoto H, Sakurai S, Kikuchi H, Kanda T, Kurokawa Y, Cho H, Nishida T, et al: English version of Japanese clinical practice guidelines 2022 for gastrointestinal stromal tumor (GIST) issued by the Japan society of clinical oncology. Int J Clin Oncol. 29:647–680. 2024.PubMed/NCBI View Article : Google Scholar
|
|
20
|
International Classification of Diseases for Oncology: ICD-11 for Mortality and Morbidity Statistics: XH9HQ1. World Health Organization, Geneva, 2025. https://icd.who.int/browse/2024-01/mms/en#2069696861.
|
|
21
|
Tsurumaru D, Nishimuta Y, Kai S, Oki E, Minoda Y and Ishigami K: Clinical significance of dual-energy dual-layer CT parameters in differentiating small-sized gastrointestinal stromal tumors from leiomyomas. Jpn J Radiol. 41:1389–1396. 2023.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Sweet T, Abraham CM and Rich A: Origin and development of interstitial cells of Cajal. Int J Dev Biol. 68:93–102. 2024.PubMed/NCBI View Article : Google Scholar
|
|
23
|
White A, Sikora J, Thannoun A and Soliman B: Gastric leiomyoma near the gastroesophageal junction causing massive gastrointestinal bleeding. Cureus. 15(e48374)2023.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Mclin VA, Henning SJ and Jamrich M: The role of the visceral mesoderm in the development of the gastrointestinal tract. Gastroenterology. 136:2074–2091. 2009.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Gou Y, Huang Y, Luo W, Li Y, Zhao P, Zhong J, Dong X, Guo M, Li A, Hao A, et al: Adipose-derived mesenchymal stem cells (MSCs) are a superior cell source for bone tissue engineering. Bioact Mater. 34:51–63. 2024.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Mihai MC, Popa MA, Șuică VI, Antohe F, Jackson EK, Leeners B, Simionescu M and Dubey RK: Proteomic analysis of estrogen-mediated enhancement of mesenchymal stem cell-induced angiogenesis in vivo. Cells. 10(2181)2021.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Radenkovic G, Radenkovic D and Velickov A: Development of interstitial cells of Cajal in the human digestive tract as the result of reciprocal induction of mesenchymal and neural crest cells. J Cell Mol Med. 22:778–785. 2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Unk M, Jezeršek Novaković B and Novaković S: Molecular mechanisms of gastrointestinal stromal tumors and their impact on systemic therapy decision. Cancers (Basel). 15(1498)2023.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Zhang W, Wang S, Zhang H, Meng Y, Jiao S, An L and Zhou Z: Modeling human gastric cancers in immunocompetent mice. Cancer Biol Med. 21:553–570. 2024.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Biagioni A, Peri S, Versienti G, Fiorillo C, Becatti M, Magnelli L and Papucci L: Gastric cancer vascularization and the contribution of reactive oxygen species. Biomolecules. 13(886)2023.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Kondo J, Huh WJ, Franklin JL, Heinrich MC, Rubin BP and Coffey RJ: A smooth muscle-derived, Braf-driven mouse model of gastrointestinal stromal tumor (GIST): Evidence for an alternative GIST cell-of-origin. J Pathol. 252:441–450. 2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Denu RA, Joseph CP, Urquiola ES, Byrd PS, Yang RK, Ratan R, Zarzour MA, Conley AP, Araujo DM, Ravi V, et al: Utility of clinical next generation sequencing tests in KIT/PDGFRA/SDH wild-type gastrointestinal stromal tumors. Cancers (Basel). 16(1707)2024.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Nishida T, Naito Y, Takahashi T, Saito T, Hisamori S, Manaka D, Ogawa K, Hirota S and Ichikawa H: Molecular and clinicopathological features of KIT/PDGFRA wild-type gastrointestinal stromal tumors. Cancer Sci. 115:894–904. 2024.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Jasek K, Buzalkova V, Minarik G, Stanclova A, Szepe P, Plank L and Lasabova Z: Detection of mutations in the BRAF gene in patients with KIT and PDGFRA wild-type gastrointestinal stromal tumors. Virchows Arch. 470:29–36. 2017.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Jašek K, Váňová B, Grendár M, Štanclová A, Szépe P, Hornáková A, Holubeková V, Plank L and Lasabová Z: BRAF mutations in KIT/PDGFRA positive gastrointestinal stromal tumours (GISTs): Is their frequency underestimated? Pathol Res Pract. 216(153171)2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Li AX, Liu E, Xie X, Peng X, Nie XB, Li JJ, Gao Y, Liu L, Bai JY, Wang TC and Fan CQ: Efficacy and safety of piecemeal submucosal tunneling endoscopic resection for giant esophageal leiomyoma. Dig Liver Dis. 56:1358–1365. 2024.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Liu X, Yu J, Li Y, Shi H, Jiao X, Liu X, Guo D, Li Z, Tian Y, Dai F, et al: Deciphering the tumor immune microenvironment of imatinib-resistance in advanced gastrointestinal stromal tumors at single-cell resolution. Cell Death Dis. 15(190)2024.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Kalfusova A, Linke Z, Kalinova M, Krskova L, Hilska I, Szabova J, Vicha A and Kodet R: Gastrointestinal stromal tumors- Summary of mutational status of the primary/secondary KIT/PDGFRA mutations, BRAF mutations and SDH defects. Pathol Res Pract. 215(152708)2019.PubMed/NCBI View Article : Google Scholar
|
